About Access Biotechnology
Access Biotechnology is a Healthcare company based in New York (United States) founded in 1986. Access Biotechnology is engaged in investing in transformative biopharma therapies. It operates on a Professional Services and Brokerage / Intermediation model. Access Biotechnology offers products and services including Biopharma Investments and Therapy Development Support. Its focus areas include Biotechnology and Biopharmaceuticals.
Company details
Access Biotechnology is focused on investing in transformative therapies for conditions with high unmet needs. Investments are made in both private and public biopharma companies across various therapeutic areas, modalities, and development stages. The portfolio includes discovery-stage technology platforms and late-stage clinical programs. A long-term orientation is adopted to support the growth of portfolio companies. Flexibility is maintained to adapt to individual opportunities and external shifts. Technical rigor is applied through medical and scientific expertise to evaluate opportunities. Collaboration with founders, management, and investors is emphasized to develop important new medicines.
- Headquarters New York, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website accessbio-tech.com
Products & Services of Access Biotechnology
Access Biotechnology offers a comprehensive portfolio of products and services, including Biopharma Investments and Therapy Development Support.
Investments are made in transformative biopharma therapies.
Support is provided for novel therapy development initiatives.
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Access Biotechnology (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Access Biotechnology
Access Biotechnology was founded in 1986.
Access Biotechnology is headquartered in New York, United States. It is registered at New York, New York, United States.
Access Biotechnology is focused on investing in transformative therapies for conditions with high unmet needs. Investments are made in both private and public biopharma companies across various therapeutic areas, modalities, and development stages. The portfolio includes discovery-stage technology platforms and late-stage clinical programs. A long-term orientation is adopted to support the growth of portfolio companies. Flexibility is maintained to adapt to individual opportunities and external shifts. Technical rigor is applied through medical and scientific expertise to evaluate opportunities. Collaboration with founders, management, and investors is emphasized to develop important new medicines.
Access Biotechnology offers Biopharma Investments and Therapy Development Support.